MRC1 and neoplasm: Furthermore, abnormal immunohistochemistry and hypermutated tumor phenotype, combined with early onset of the disease (29 years), recently led to the suggestion that breast cancer is part of the tumor spectrum of the constitutional mismatch repair deficiency (CMMRD) syndrome caused by biallelic pathogenic germline variants of MMR genes [13].